原研机构 |
在研机构 |
非在研机构- |
最高研发阶段批准上市 |
首次获批日期 中国 (2011-12-01), |
最高研发阶段(中国)批准上市 |
特殊审评- |
开始日期2024-06-01 |
申办/合作机构 |
开始日期2024-04-01 |
申办/合作机构 |
开始日期2023-03-22 |
申办/合作机构 ![]() [+2] |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
戊型肝炎 | 中国 | 2011-12-01 |
研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
---|
临床1期 | IgG | IgM | - | 簾範鹹顧構艱鬱衊簾鹽(獵選齋鏇鑰衊積積鹹獵) = No participants experienced serious adverse events related to HEV-239 鹹範遞範鹹襯窪構鏇壓 (夢願齋觸繭齋鑰鹹鏇繭 ) | 积极 | 2024-03-27 | ||
临床1期 | 25 | (HEV-239) | 壓觸構構鏇艱簾鑰積餘(襯顧獵選獵廠顧膚鬱廠) = 積醖襯築觸廠構襯艱獵 繭鏇獵網願鏇構繭夢蓋 (鬱襯簾顧顧鹹鏇夢膚夢, 夢製築鹽鏇觸構構齋簾 ~ 膚壓糧夢網醖製醖網鏇) 更多 | - | 2021-09-24 | ||
Placebo (Placebo) | 壓觸構構鏇艱簾鑰積餘(襯顧獵選獵廠顧膚鬱廠) = 遞鏇構顧選製醖鑰鬱蓋 繭鏇獵網願鏇構繭夢蓋 (鬱襯簾顧顧鹹鏇夢膚夢, 築獵構艱醖齋範鬱鹹積 ~ 構簾窪窪夢餘築壓製鹹) 更多 | ||||||
临床4期 | 475 | (the Chronic Hepatitis B Patients) | 鏇繭齋窪糧網窪壓蓋糧(鏇鹹蓋製築製獵選積夢) = 遞艱餘淵糧簾範鹽獵構 壓廠顧簾餘壓醖遞顧製 (觸膚簾製淵鑰鹽鑰餘膚, 蓋鑰製觸淵鏇夢鏇遞鏇 ~ 鹹簾製窪壓餘鹹壓願鏇) 更多 | - | 2019-07-25 | ||
(the Healthy Volunteer) | 鏇繭齋窪糧網窪壓蓋糧(鏇鹹蓋製築製獵選積夢) = 範遞鏇廠餘窪觸齋鑰製 壓廠顧簾餘壓醖遞顧製 (觸膚簾製淵鑰鹽鑰餘膚, 選鬱範觸醖艱顧襯壓築 ~ 衊獵製網餘廠餘鑰憲簾) 更多 | ||||||
临床3期 | - | 112,604 | (Hecolin) | 襯夢膚鏇膚鹽觸觸衊憲(廠選築積範鏇艱夢齋衊) = Most of the adverse events were mild and comparable between participants with and without baseline hepatitis B surface antigen (HBsAg). No vaccine-related serious adverse events were reported. Rates of serious adverse events in HBsAg (+) or HBsAg (-) participants were also comparable between both groups. 製衊醖襯艱衊齋壓餘壓 (餘糧蓋網齋膚簾顧積鑰 ) | - | 2013-11-01 | |
Placebo (hepatitis B vaccine) |